Jeffrey Solzak

3PUBLICATIONS
31CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 13, 2022
Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer.

Milan Radovich, Jeffrey P Solzak, Chao J Wang

|Dec 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.

Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger

Pageof 1